Rheumatic Diseases and Metabolic Complications in HIV/AIDS Patients with Highly Efficient Antiretroviral Treatment
Keywords:
rheumatic diseases, metabolic complications, HIV/AIDS, highly efficient antiretroviral treatmentAbstract
Introduction: HIV/AIDS infection is one of the main health problems worldwide, with high morbidity and mortality. Different epidemiological studies have confirmed that 36.3 million people worldwide were living with HIV until 2015. So far, 78 million have been infected since 1981, the year in which the epidemic began, and 25% of patients do not know they are infected, which spreads infection.
Objective: To carry out a literature review about HIV/AIDS infection, its complications in rheumatic metabolic manifestations, and its response to highly efficient antiretroviral treatment.
Method: A literature search was carried out in the databases PudMed/ MEDLINE, Cumedand Lilac, as well as in the regional information sources SciELO and ScienceDirect, using the key phrases manifestaciones reumáticas y VIH-SIDA [rheumatic manifestations and HIV-AIDS],complicaciones metabólicas y VIH-SIDA [metabolic complications and HIV-AIDS],tratamiento antirretroviral de alta eficiencia y VIH-SIDA [ high-efficiency antiretroviral treatment and HIV-AIDS], in order to recover the articles about HIV-AIDS and rheumatic and metabolic complications and their response to highly efficient antiretroviral treatment.
Results: 78 articles and nine texts dealing about the aforementioned topics were recovered; of them, 55 documents that are part of our bibliographical references were useful for our purposes, which were grouped according to the different topics proposed for this study. We reached useful conclusions for our scientific community.
Conclusions: Rheumatic and autoimmune diseases have been diagnosed very frequently in patients infected with HIV/AIDS in Cuba and worldwide during the era prior to highly efficient antiretroviral treatment. Its incorporation into the therapeutic approach has increased the survival expectations of these patients, in addition to the substantial decrease in the appearance of clinical symptoms and conditions, especially the inflammatory arthritic conditions, seronegative spondyloarthropathies, psoriasis and opportunistic infections.
Downloads
References
UNAIDS. Global Statistics Fact Sheet. UNAIDS. 2016 update 2018. [acceso 12 Jun 2018]. Disponible en: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
Yen YF, Chuang PH, Jen IA, Chen M, Lan YC, Liu YL et al. Incidence of autoimmune diseases in a nationwide HIV/AIDS patient cohort in Taiwan, 2000–2012. Ann Rheum Dis. 2017 Apr;76(4):661-5.
Lamotte Castillo JA. Infección por VIH/SIDA en el mundo actual. MEDISAN [Internet]. 2014 Jul [citado 12 Jun 2018];18(7):[aprox. 12 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192014000700015
Pérez C, Vázquez P, Wolf M, Afani A, Wu E, Beltrán C. Síndrome de Inmunodeficiencia Adquirida VIH/SIDA. Serie Guías Clínicas. Capítulo I. Diagnóstico de la infección por VIH. Rev Chil Infect [Internet]. 2010 [citado 12 Jun 2018];27(3):[aprox. 18 p.]. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-10182010000300013
Araújo LF. El origen del SIDA después de trés decádas desde sus primeros diagnósticos. Psicolog Soc [Internet]. 2014 [citado 12 Jun 2018];26(1:[aprox. 2 p.]. Disponible en: http://www.scielo.br/pdf/psoc/v26n1/27.pdf
Registro informatizado de Estadísticas de la transmisión VIH-SIDA. Ministerio de Salud Pública de Cuba. La Habana: MINSAP; 2015.
Hernández Requejo D, Pérez Ávila J, Cano Pérez A. Enfermedades oportunistas en pacientes VIH/sida con debut de sida que reciben tratamiento antirretroviral. Rev Cubana Invest Bioméd [Internet]. 2015 [citado 12 Jun 2018];34(3):[aprox. 6 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002015000300006
Reyes Llerena GA, Guibert Toledano M, Millán JC. Manifestaciones reumáticas en la epidemia VIH/SIDA en la era previa a la terapia antirretroviral sumamente activa en Cuba. Una puesta al día. Rev Peruana Reumatolog. 2016;22(3):25-33.
Adizie T, Moots RJ, Hodkinson B, French F, Adebajo AO. Inflammatory arthritis in HIV positive patients: A practical guide. BMC Infect Dis [Internet]. 2016 [citado 12 Jun 2018];16:[aprox. 6 p.]. Disponible en: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1389-2
Winchester R, Bernstein DH, Fisher AD, Enlow R, Solomon G. The Co-Ocurrence of Reiter´s Syndrome and adquired Inmunodeficiency. Ann Intern Med. 1987;106:19-26.
Espinoza LR, Aguilar JL, Berman A, Gutierrez F, Vasey FB, Germain BF. Rheumatic manifestations of human immunodeficiency Virus Infection. Arthritis Rheumatic. 1989;32(12):1615-22.
Reveille JD. The changing spectrum of rheumatic diseases in human immunodeficiency virus infection. Semin Arthritis Rheum. 2000;30(3):147-166.
Medina Rodríguez F, Guzman C, Lara LJ, Hermida C, Alboukrek D, Cervera H et al. Rheumatic manifestations in human Immunodeficiency positive and negative individuals: A Study of 2 populations with similar risk factors. J Rheumatol. 1993;20(11):1880-4.
Walker UA, Tindall A, Daikeler T. Rheumatic conditions in human immunodeficiency virus infection. Rheumatolog (Oxford). 2008 Oct;47(10): 1592.
Buskila D, Gladman DD, Langevitz P, Bookman AA, Fanning M, Salit E. Rheumatologic manifestations of infection with the human immunodeficiency virus (HIV). J Reumatolog. 1990;17(9):1202-6.
Berman A, Espinoza LR, Díaz JD, Aguilar JL, Rolando T, Vasey FB et al. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med. 1988 Jul;85(1):59-64.
Marque J, Restrepo CS, CandiL, BermanA, Espinoza LR. Human immunodeficiency virus-associated rheumatic disorders in the HAART era. J Rheumatol. 2004;31(4):741-6.
Berman A, Cah P, Perez H. Human immunodeficiency virus infection associated arthritis: clinical characteristics, J Rheumatol. 1999;26(5):1158-62.
Reyes Llerena GA. Guibert Toledano M. Hernández Martínez A. Millán JC. Patrón epidemiológico clínico de las espondiloartropatías seronegativas en una cohorte VIH-SIDA. Rev Colomb Reumatolog. 1997;4(4):164-8.
Huang YM, Hong XZ, Xu JH, Luo JX, Mo HY, Zhao HL et al. Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome. Immunol Res. 2016;64(3):641-52.
Sax PE, Wohl D, Yin MT, Post F, DeJesus E, SaagM et al. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double- blind, phase 3, non-inferiority trials. Lancet. 2015;385(9987): 2606-15.
Maganti RM, Reveille JD, Wiliams FM. Theraphy insight; the changing spectrum of rheumatic diseases in HIV Infection. Nat Clin Pract Rheumatol. 2008 Aug; 4(8):428-38.
Reveille John D, Rashmi M. Maganti R. Rheumatic manifestations in the human immunodeficiency virus infection. In: Firenstein: Kelley's Textbook of Rheumatology, 8th Edition. Ed. Saunders Elsevier; 2009.
Sharma SK, Soneja M. HIV& immune reconstitution inflammatory syndrome (IRIS). Indian J Med Res [Internet]. 2011 [citado 12 Jun 2018];134(6):[aprox. 7 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284095/
Calabresse LH, Kirchner E, Sherstha R. Rheumatic complications of human immunodeficiency virus infection in the Era of highly active antirethroviral theraphy; emergence of a news syndrome of immune reconstitution and changing patterns of diseases. Semin Arthritis Rheum 2005; 35; 166-74.
Zhang X, Li H, Li T, Zhang F, Han Y. Distinctive rheumatic manifestations in 98 patients with human immunodeficiency virus infection in China. J Rheumatol . 2007 Aug;34(8):1760-4.
MT Y, Lund E, Shah J, Zhang CA, Foca M, Neu N, et al. Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life. AIDS. 2014;28(3):345-53.
Foundation NO. Clinicians guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010.
European AIDS Clinical Society (EACS). Guidelines. Version 8, October 2015. Update: 2018 Available at: http://www.eacsociety.org/files/2-english_rev-20151221.pdf
Navarro Despaigne D, Reyes LLerena Gil A, Infante Amorós A, Guibert Toledano M, y cols. Guías nacionales para el diagnóstico y tratamiento de la Osteoporosis. Soc. Cubana de Endocrinología. Soc. Cubana de Reumatología. Rev Cubana Endocrinol [Internet]. 2014 [citado 12 Jun 2018];25(1):[aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532014000100001
Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20(17): 2165-74.
Khan AA, Sandor GK, Dore E, Morrison AD, Alsahli M, Amin F et al. Bisphosphonate associated osteonecrosis of the jaw. J Rheumatol. 2009 Mar;36(3):478-90.
McComsey GA, Tebas P, Shane E, Yin MT, Turner Overton E, JS Huang et al. Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers Clinic Infect Diseases [Internet]. 2010 [citado 12 Jun 2018];51(8):[aprox 7 p.]. Disponible en: https://academic.oup.com/cid/article/51/8/937/332474
Collin F, Duval X, Lemoing V, Piroth L, Al Kaied F, Massip P et al. Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults. AIDS [Internet]. 2009 [citado 12 Jun 2018];23(8):[aprox. 3 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855855/
Fakruddin JM, Lawrence J. HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Arch Virol. 2005;150(1):67-78.
Borderi M, Gibellini D, De Crignis E, Ponti C, Cimatti L, Biaguetti C et al. HIV-1 Induces apoptosis in primary osteoblasts: an alternative mechanism in the development of osteopenia and osteoporosis. Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections. Montreal [Internet]. 2009 [citado 12 Jun 2018]. Disponible en: http://www.natap.org/2009/CROI/hivinflammation.pdf
Guaraldi G, Orlando G, Squillace N. Prevalence of secondary causes of osteoporosis among HIV-infected individuals. 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. San Francisco, CA; 24–26 September 2006.
Rodríguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV Positive patients. AIDS Res Hum Retroviruses. 2009;25(1):9-14.
Yin MT, Brown TT. HIV and Bone Complications: Under studied Populations and New Management Strategies. Current HIV/AIDS Reports. 2016;13(6):349-58.
Chak-Sing Lau, Li P. Epidemiology: The effects of AIDS on the prevalence of rheumatic diseases. Nature Reviews Rheumatolog. 2017;3(1):8.
Gutiérrez F, Padilla S, Masia M, Flores J, Boix V, Merino E. Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain. J Adquir Inmune Defic Syndr. 2006;42(3):286–92.
Woo S, Hellstein J, Kalmar J. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144(10):753-61.
Stoll M, Schmidt RE. HIV/Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART. AIDS Rep. 2004 Sep;1(3):122-7.
Crum-Cianflone NF. Immune reconstitution inflammatory syndromes: what's new? AIDS Read. 2006 Apr;16(4):199-206.
Trøseid M, Eskesen A, Bruun JN. Immune reconstitution inflammatory syndrome and treatment of HIV infection. Nor Laegeforen. 2009 Dec 3;129 (23):2484-7.
Lichtenstein KA, Ward DJ, Moorman AC, Delaney KM, Young B, Palella JFJ et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001;15(11):1389-98.
Shevitz A, Wanke CA, Falutz J, Kotler DP. Clinical perspectives on HIV-associated lipodystrophy syndrome: An update. AIDS. 2001;15(5):1917-30.
Baril JG, Junod P, Leblanc R, Dion H, Therrien R, Laplante F et al. HIV-associated lipodystrophy syndrome: A review of clinical aspects. Can J Infect Dis Med Microbiol. 2005 Jul;16(4):233-43.
Capeau J, Raffi F, Savès M, et al. Lipodystrophy and metabolic disorders in HIV-infected patients treated by protease inhibitors: Is there an association? Antivir Ther. 2000;5(Suppl 5):55.
Piroth L, Grappin M, Petit JM, Buisson M, Duong M, Chavanet P et al. Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy. Scand J Infect Dis. 2001;33(7):559-60.
Manfredi R, Calza L, Chiodo F. Gynecomastia, lipodystrophy syndrome, and dyslipidemia occurring or worsening during antiretroviral regimens other than protease inhibitor-based ones. J Acquir Immune Defic Syndr. 2004;35:99-102.
Ammassari A, Antinori A, Cozzi-Lepri A, Trotta MP, Nasti G, Ridolfo AL et al. Relationship between HAART adherence and adipose tissue alterations. J Acquir Immune Defic Syndr. 2002;31(S3):S140-4.
Mayer KH, Dubé MP, Sprecher D, Henry WK, Aberg JA, Torriant FJ. Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adult Infected with Human Inmunodeficiency Virus and Receiving Antirretroviral Therapy: Recommendationsof the Adults AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Clinical Infectious Disease [Internet]. 2000 [citado 12 Jun 2018];31(5):[aprox. 12 p.]. Disponible en: https://academic.oup.com/cid/article/31/5/1216/329168
Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F et al PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013 Apr 4;368(14):1279-90.
AIDS Info 2005. Efectos secundarios de los medicamentos contra el VIH. Información de salud para los pacientes noviembre del 2005. [Internet]. 2005 [citado 12 Jun 2018] https://aidsinfo.nih.gov/news/305/fda-aprueba-nevirapina-para-tratar-el-vih
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
